<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[25, 36] systolic function of the left ventricle, arrhythmia and clinical symptoms<br>[84, 88] Left ventricular systolic function<br>[106, 107] arrhythmia<br>[127, 130] left ventricular dilation<br>[151, 160] end systolic and diastolic volumes of the left ventricle<br>[171, 173] Antiarrhythmic action<br>[191, 197] progression of left ventricular systolic dysfunction<br></td>
<td width=33%>
[25, 36] systolic function of the left ventricle, arrhythmia and clinical symptoms<br>[84, 88] Left ventricular systolic function<br>[106, 107] arrhythmia<br>[127, 130] left ventricular dilation<br>[151, 160] end systolic and diastolic volumes of the left ventricle<br>[171, 173] Antiarrhythmic action<br>[191, 197] progression of left ventricular systolic dysfunction<br></td>
<td width=33%>
[25, 45] systolic function of the left ventricle, arrhythmia and clinical symptoms in patients on thrombolytic therapy (TLT).<br>[84, 88] Left ventricular systolic function<br>[106, 112] arrhythmia was analysed at Holter monitoring<br>[125, 130] progression of left ventricular dilation<br>[151, 160] end systolic and diastolic volumes of the left ventricle<br>[171, 173] Antiarrhythmic action<br>[191, 198] progression of left ventricular systolic dysfunction and<br></td>
</tr>
